Skip to main content

Author: Tom Wilemon

Vanderbilt Health Pleasant View now open

Sep. 30, 2022—The new Vanderbilt Health Pleasant View outpatient clinic offers greater convenience to primary care and specialized medical services for patients in Cheatham, Montgomery and Robertson counties.

Read more


Vanderbilt lauded for pancreatic cancer, pancreatitis care

Sep. 29, 2022—Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

Read more


Lung cancer detection program lands grant renewal

Sep. 15, 2022—The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.

Read more


Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial

Sep. 13, 2022—Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

Read more


Grant supports research to study gastric cancer origins

Sep. 1, 2022—Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.

Read more


Chic Aweareness ovarian cancer fundraiser moves online

Sep. 1, 2022—Chic Awearness, a fundraiser for ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC), is an online event this year from now throughout September with an in-store shopping opportunity to close out the month called Chic Week.

Read more


Abramson, Eng, Johnson named to new VICC roles

Aug. 18, 2022—Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles.

Read more


Trial for colorectal cancer drug reaches primary endpoint

Aug. 17, 2022—A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.

Read more


Couple’s gift helps support immunotherapy research

Aug. 11, 2022—Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.

Read more


Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding

Aug. 5, 2022—A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time.

Read more


Study reveals need for matching targeted therapies with EGFR subtypes

Jul. 28, 2022—A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.

Read more


Holowatyj named chair of scientific advisory board for ACPMP Research Foundation

Jul. 15, 2022—Vanderbilt's Andreana Holowatyj, PhD, MSCI, has been named the inaugural chair of the scientific advisory board for the Appendix Cancer Pseudomyxoma Peritonei Research Foundation.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more